Report Finds Mesothelioma Survival Advantage in Some Type of P/D Surgery, According to Surviving Mesothelioma
Raleigh, NC (PRWEB) April 24, 2017 -- New research based on the cases of 314 pleural mesothelioma patients suggests that standard P/D and extended P/D may extend survival while the more conservative partial P/D does not. Surviving Mesothelioma has details of the new study. Click here to read the full article.
Surgeons from 11 Italian institutions reviewed malignant pleural mesothelioma cases that occurred between 2011 and 2014 to evaluate patients who had undergone one of three types of P/D surgery.
“Whether the P/D is extended or not, it shows similarly good outcomes in terms of early results and survival rate,” writes study author Giuseppe Marulli of the University of Padova in the European Journal of Cardio-Thoracic Surgery. “In contrast, a partial pleurectomy, which leave gross tumour behind, has no impact on survival.”
In contrast to the more radical extrapleural pneumonectomy surgery, all three types of P/D surgery leave both lungs in place and remove all or part of the pleural membrane along with various amounts of other at-risk tissues.
“This study helps to clarify the role of P/D surgery in mesothelioma treatment and may help patients and their doctors to make more informed decisions based on their individual situation and goals,” says Alex Strauss, Managing Editor for Surviving Mesothelioma.
For more on the new P/D study, including an explanation of the three types of P/D surgery, see Lung-Sparing Surgery and Mesothelioma Survival, now available on the Surviving Mesothelioma website.
Marulli, G, et al, “Pleurectomy–decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study”, April 12, 2017, European Journal of Cardio-Thoracic Surgery, Epub ahead of print, https://academic.oup.com/ejcts/article-abstract/doi/10.1093/ejcts/ezx079/3608982/Pleurectomy-decortication-in-malignant-pleural?redirectedFrom=fulltext
For more than a decade, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.
Michael Ellis, Cancer Monthy, http://www.survivingmesothelioma.com, +1 (919) 570-8595, [email protected]
Share this article